Skip to content

RIGEL PHARMACEUTICALS INC

RIGL

CIK 0001034842 · Pharmaceutical Preparations · Nasdaq

  • RIGEL PHARMACEUTICALS INC (until 2026-06-17)
← back to feed
Revenue (TTM)
$283.3M
+64.1% YoY Q1 Apr 2026
Net Income (TTM)
$107.61M
+1,999.1% YoY Q1 Apr 2026
EPS Diluted (TTM)
$5.81
+1,867.7% YoY Q1 Apr 2026
Gross Margin
6.2%
Q1 Apr 2026
Operating Margin
40.3%
Q1 Apr 2026
Net Margin
38.0%
Q1 Apr 2026
Free Cash Flow (TTM)
−$8.53M
Q1 Apr 2026
Cash
$24.41M
Q1 Apr 2026
Total Debt
$45M
Q1 Apr 2026
Shares Outstanding
18.5M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings